Previous Article | Next Article 
Journal of Bacteriology, April 2000, p. 2096-2103, Vol. 182, No. 8
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of the Enzymatic Component
of Clostridium perfringens Iota-Toxin
Masahiro
Nagahama,
Yoshihiko
Sakaguchi,
Keiko
Kobayashi,
Sadayuki
Ochi, and
Jun
Sakurai*
Department of Microbiology, Faculty of
Pharmaceutical Sciences, Tokushima Bunri University, Tokushima
770-8514, Japan
Received 4 October 1999/Accepted 20 January 2000
 |
ABSTRACT |
The iotaa component (ia) of
Clostridium perfringens ADP ribosylates nonmuscle
/
actin and skeletal muscle
-actin. Replacement of Arg-295 in
ia with alanine led to a complete loss of
NAD+-glycohydrolase (NADase) and ADP-ribosyltransferase
(ARTase); that of the residue with lysine caused a drastic
reduction in NADase and ARTase activities (<0.1% of the
wild-type activities) but did not completely diminish them.
Substitution of alanine for Glu-378 and Glu-380 caused a complete loss
of NADase and ARTase. However, exchange of Glu-378 to aspartic
acid or glutamine resulted in little effect on NADase activity but
a drastic reduction in ARTase activity (<0.1% of the wild-type
activity). Exchange of Glu-380 to aspartic acid caused a drastic
reduction in NADase and ARTase activities (<0.1% of the
wild-type activities) but did not completely diminish them; that of the
residue to glutamine caused a complete loss of ARTase activity.
Replacement of Ser-338 with alanine resulted in 0.7 to 2.3% wild-type
activities, and that of Ser-340 and Thr-339 caused a reduction in these
activities of 5 to 30% wild-type activities. The kinetic analysis
showed that Arg-295 and Ser-338 also play an important role in the
binding of NAD+ to ia, that Arg-295, Glu-380,
and Ser-338 play a crucial role in the catalytic rate of NADase
activity, and that these three amino acid residues and Glu-378 are
essential for ARTase activity. The effect of amino acid replacement
in ia on ARTase activity was similar to that on lethal
and cytotoxic activities, suggesting that lethal and cytotoxic
activities in ia are dependent on ARTase activity.
 |
INTRODUCTION |
Clostridium perfringens
type E produces iota-toxin, which is lethal and dermonecrotic (35,
37). Iota-toxin is a binary toxin which is composed of an
enzymatic component called iotaa (ia) and a
binding component called iotab (ib).
ia causes ADP-ribosylation of skeletal muscle
-actin
and nonmuscle
/
actin, and ib is required for
penetration of ia into the cytosol (1, 2, 3, 12, 34,
38, 40). It has been reported that iota-toxin may be associated
with antibiotic-associated colitis caused by C. perfringens
type E in rabbits (9, 26). In addition, C. spiroforme is known to cause antibiotic-associated enterotoxemia of rabbits and to produce iota-like-toxin (8), which shows partial antigenic identity with iota-toxin (32). Several
workers have reported the presumptive involvement of iota-like-toxin in sudden outbreaks of enteritis in rabbit colonies (17, 20). It therefore appears that iota-toxin also is able to be a major agent
in enterotoxemia (16, 37). Stiles and Wilkins
(43) reported the purification of iota-toxin from cultures
of C. perfringens type E. However, large amounts of
iota-toxin were difficult to purify from the culture supernatant fluid
of C. perfringens type E by to their method. To
understand the mode of action of iota-toxin, large amounts of highly
purified ia and ib are required. Bacillus subtilis is reported to produce and secrete secretory proteins of
other gram-positive bacteria (39). We first tried to purify large amounts of ia from cultures of a B. subtilis transformant carrying the component gene.
Bacterial ADP-ribosylating toxins, such as diphtheria toxin (DT)
(11), Pseudomonas exotoxin A (ETA)
(45), cholera toxin (CT) (42), Escherichia
coli heat-labile enterotoxin (LT) (42), pertussis toxin
(22), Pseudomonas exoenzyme S (ExoS)
(24), Clostridium botulinum C3 enzyme (C3)
(5), C. botulinum C2 toxin (C2 toxin)
(4), C. spiroforme toxin (2), and
epidermal cell differentiation inhibitor (EDIN) from
Staphylococcus aureus (44), have been studied as
agents that contribute to the pathogenesis of bacteria. The Glu-14 and
-226 residues in ia are included within the E-X-X-X-X-W
sequence in the active sites of DT and ETA. ADP-ribosylating toxins
such as CT, LT, and C3 are known to contain three conserved regions,
aromatic residue-R/H, E-X-E, and hydrophobic residue-S-T-S-hydrophobic residue, in the cavity formed by the
/
motif (14). The
analysis of the LT crystal suggested that the nicotinamide ring of
NAD+ docks into the cavity (14). The role of
these regions is thought to be as follows. The polar side chains of
E-X-E extend toward the catalytic cavity and the consensus sequence
involved in forming the NAD+ cleft; an aromatic residue-R/H
located deep in the cavity binds NAD+; and the S-T-S
consensus sequence is folded in a
strand representing the floor of
the cavity. The Glu-378 and -380 residues in ia are included within the E-X-E sequences essential for the enzymatic activities of CT, LT, and ExoS. The Arg-295 residue in the component is
present in the aromatic residue-R/H sequence. Ser-338, Ser-340, and
Thr-339 are present in the S-T-S consensus sequence.
Recently, Perelle et al. (31) reported that Glu-378,
Glu-380, and Arg-295 are involved in the ADP-ribosylation of
ia. Damme et al. (13) reported the pivotal
role of Glu-378 in ia which was photoaffinity labeled
with [carbonyl-14C]NAD+.
However, the reaction mechanism of ia has not been
investigated by use of conservative substitutions and kinetic analysis.
To study the functional roles of these conserved regions of
ia in more detail, we replaced Arg-295, Glu-14, Glu-226,
Glu-378, Glu-380, Ser-338, Ser-340, and Thr-339 with various amino
acids by site-directed mutagenesis, determined the
ADP-ribosyltransferase (ARTase) and NAD+-glycohydrolase (NADase) activities of these
variant components, determined the cytotoxic and lethal activities of
these variant components in the presence of ib, and
analyzed the enzymatic properties of these components.
 |
MATERIALS AND METHODS |
Materials.
Restriction endonucleases and DNA-modifying
enzymes were obtained from Takara Shuzo (Kyoto, Japan) and Toyobo
(Osaka, Japan), respectively. pT-7 Blue was obtained from Novagen
(Madison, Wis.). [adenylate-32P]NAD+ and
[carbonyl-14C]NAD+ were obtained
from New England Nuclear (Boston, Mass.) and Amersham (Tokyo, Japan),
respectively. Purified rabbit muscle actin was purchased from
Worthington Biochemical Corp., Lakewood, N.J. All other chemicals were
of analytical grade.
Bacterial strains and plasmids.
C. perfringens type E
strain NCIB 10748, kindly donated by M. Popoff (Institut Pasteur,
Paris, France), was grown in brain heart infusion broth under anaerobic
conditions. Plasmid DNA was extracted and purified as described by
Perelle et al. (30). E. coli JM109 or C600 was
the host for the plasmid used. B. subtilis ISW1214 was used
for production of the toxin (28).
DNA cloning and expression of the ia gene.
C.
perfringens type E strain NCIB 10748 carrying the entire
iota-toxin gene was PCR amplified using a set of primers. A pair of
primers for ia (5'-GAGAATTCAGAAAATACAATC-3' and
5'-TCTTATCATAGCTGTAAGTG-3') was designed from the published
ia sequence (30). The PCR was carried out for 25 cycles under standard reaction conditions with a GeneAmp DNA
amplification reagent kit (Perkin-Elmer Cetus, Norwalk, Conn.). After
PCR amplification, the 1.7-kbp fragment obtained was gel purified and
cloned into pT-7 Blue (pTIA). The 1.7-kbp EcoRI/XbaI fragment of the wild-type
ia gene was subcloned from pTIA into the pHY300PLK
(E. coli-B. subtilis shuttle vector) SmaI site
and transformed into B. subtilis ISW1214.
Site-directed mutagenesis.
The 1.7-kbp
EcoRI/XbaI fragment of the ia gene,
encoding the entire reading frame for the 454 amino acids of
ia, was introduced into the SmaI site of the
pUC19 vector (pUIA) and used as a template for mutagenesis.
Site-directed mutagenesis was carried out by the unique restriction
enzyme site elimination technique with a Transformer mutagenesis kit
(Clontech Laboratories, Inc., Palo Alto, Calif.) and synthetic
oligonucleotide primers having mutations as described previously
(28, 29). All mutants were obtained by this method and were
identified by sequencing with a Dye Deoxy termination kit (Applied
Biosystems), sequencing primers, and a DNA sequencer (374A; Applied Biosystems).
Purification of ia and ib from C. perfringens.
Native ia and ib were
purified from culture supernatant fluid of C. perfringens
NCTC 8084 as described previously (43).
Determination of lethal activity.
Serial twofold dilutions
of ia and 5 µg of ib were mixed in 0.01 M
phosphate buffer (pH 7.0) containing 0.9% NaCl (final volume, 1.0 ml).
The mixture (0.1 ml) was injected intravenously into adult mice (about
25 g), and deaths occurring within 24 h were recorded.
Determination of cytotoxic activity.
Vero cells were
cultivated in Dulbecco modified Eagle medium supplemented with 10%
fetal calf serum. For cytotoxicity assays, the cells were inoculated
into 48-well tissue culture plates (Falcon, Oxnard, Calif.). Serial
dilutions of various concentrations of ia and 200 ng of
ib per ml were mixed in Dulbecco modified Eagle medium and
inoculated onto a cell monolayer. The cells were observed for
morphological alterations 8 h after inoculation.
NADase assay.
NAD+ glycohydrolysis due to
ia was determined by the release of free radiolabeled
nicotinamide into solution, resulting from the hydrolysis of
[carbonyl-14C]NAD+ (41 mCi/mmol)
(46). The assays were performed at various NAD+
concentrations in the presence of ia in a final volume of
50 µl of 40 mM Tris-HCl (pH 7.5) containing 10 mM EDTA, 10 mM
dithiothreitol, and 100 µg of bovine serum albumin/ml at 37°C for
6 h. After incubation, hydrolyzed nicotinamide was separated from
NAD+ by the addition of 200 µl of water-saturated ethyl
acetate. The amount of nicotinamide in the ethyl acetate phase was
determined by liquid scintillation counting. The data were corrected by
subtraction of the radioactivity due to nonenzymatic hydrolysis of
NAD+.
ARTase assay.
ARTase activity on globular (G)-actin
due to ia was monitored by the incorporation of the
radiolabeled ADP-ribose moiety of NAD+ into the
trichloroacetic acid (TCA)-precipitable protein fraction of the
reaction mixture.
[adenylate-32P]NAD+ (800 Ci/mmol)
was diluted to a final specific activity of 16 Ci/mmol with unlabeled
NAD+ to give a final concentration of 5 µM. Reaction
mixtures in a final volume of 0.1 ml of 20 mM Tris-HCl buffer (pH 7.5)
containing 1 mM dithiothreitol, 40 µM ATP, 40 µM CaCl2,
50 µM MgCl2, and the specified concentrations of
NAD+ and actin for the kinetic experiments (see below) were
incubated with ia samples at 37°C for 60 min. After
incubation, 0.5 ml of cold 7.5% TCA and 10 µg of bovine serum
albumin were added, and the reaction mixtures were allowed to stand for
30 min on ice. Proteins were precipitated by centrifugation at
10,000 × g for 20 min. The precipitate was washed
twice by centrifugation in 1 ml of ice-cold 7.5% TCA. The precipitated
proteins were dissolved in 10 µl of 0.02 M Tris-HCl buffer (pH 7.5)
containing 3% sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol, 5%
glycerol, and 0.001% bromophenol blue and then subjected to
SDS-polyacrylamide gel electrophoresis (PAGE) (12% polyacrylamide
gel). The gel was stained with Coomassie blue, destained, and dried in
a gel dryer; labeled actin was analyzed with a Fuji BAS 2000 system
(Fuji Photo Film Co., Ltd., Tokyo, Japan). The radioactive bands were
excised from the gel, and the incorporated radioactivity was counted in a liquid scintillation counter (Aloka Co., Ltd., Tokyo, Japan).
Kinetic experiments.
Initial rate data for the
single-substrate NADase reaction were collected under conditions
where NAD+ concentrations were varied from 0.2 to 2.5 Km. Initial rate data for the ARTase
reaction were similarly determined for NAD+ binding at a
fixed actin concentration (0.23 µM) and various NAD+
concentrations from 0.2 to 2.5 Km and for actin
binding at a fixed NAD+ concentration (5 µM) and various
actin concentrations from 0.2 to 2.5 Km. The
kinetic parameters were obtained by analysis of a Hanes-Woolf plot
(18).
Other procedures.
Protein was assayed by the method of Lowry
et al. (25). Double-gel immunodiffusion and SDS-PAGE were
carried out as described previously (23, 27).
Anti-ia antiserum was prepared by immunizing a rabbit with
50 µg of purified ia as described previously
(36). Determination of the N-terminal amino acid sequence
was performed as described previously (21).
 |
RESULTS |
Purification of ia from culture supernatant fluid of
the B. subtilis transformant carrying the
ia gene.
Growth of the B. subtilis
transformant reached a maximum in Luria-Bertani broth after 7 h of
incubation. The time course of ia production (ARTase
activity) was roughly parallel to the growth of the transformant.
ARTase activity remained constant in the culture within 5 h
after growth stopped. Ammonium sulfate (313 g/liter) was added
to the culture supernatant fluid and allowed to stand overnight at
4°C. SDS-PAGE of the ammonium sulfate fraction revealed that the
corresponding band of ia (about 43 kDa) was dominant in the
fraction (Fig. 1), suggesting that the
B. subtilis transformant produces and secretes large amounts
of the component. The ammonium sulfate fraction was dialyzed against
0.02 M Tris-HCl buffer (pH 7.5) and loaded onto a DEAE-Sepharose
CL-6B column, previously equilibrated with the same buffer.
Elution of the column was done with a 0 to 0.1 M NaCl linear gradient
(300 ml total) in 0.02 M Tris-HCl buffer (pH 7.5). Figure
2 shows a typical elution profile of the
ammonium sulfate fraction applied to the column. The eluted fractions
were separated into two peaks, based on the absorbance at 280 nm. An
immunodiffusion test of each fraction was performed with
anti-ia antiserum. Only the second peak (fractions 61 to
68) reacted with the antiserum. Furthermore, the second peak showed
ARTase activity, which was completely inhibited by anti-ia antiserum (data not shown). SDS-PAGE analysis of
the preparation (50 µg of protein) revealed only one band of
approximately 43 kDa, as shown in Fig. 1. An immunodiffusion test
showed that the test preparation and the native component reacted with
anti-ia antiserum, showing a single fused precipitin line
(data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE analysis of purified ia. Lanes: 1, molecular mass standards; 2, ammonium sulfate fraction; 3, purified r
ia.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
DEAE-Sepharose CL-6B column chromatography of the
ammonium sulfate fraction. The ammonium sulfate fraction obtained from
cultures of the B. subtilis transformant carrying the
ia gene was applied to a DEAE-Sepharose CL-6B column (2 by
25 cm) equilibrated with 10 mM Tris-HCl buffer (pH 7.5). After
application, the column was washed with 150 ml of the same buffer and
then eluted with 300 ml of a linear gradient of 0 to 0.1 M NaCl in the
same buffer. The fractions were collected and assayed for
A280. The heavy horizontal bar indicates the
peak containing ia.
|
|
Furthermore, the N-terminal sequence of the purified protein was
identical to the amino acid sequence of i
a expected from
the gene and the native component. The purification steps for
recombinant i
a (r i
a) are summarized in Table
1. The final step
resulted in a
homogeneous product that was purified approximately
ninefold, starting
from the ammonium sulfate fraction, with a
yield of about 75% with
respect to ARTase activity. The amount
of purified r i
a
obtained from 1,000 ml of culture was about 35
mg. Stiles and Wilkins
(
43) reported that the dose required
to kill 50% of mice
injected intraperitoneally was 0.62 µg of
i
a in the
presence of 0.94 µg of i
b, but administration of 0.31
µg of i
a and 0.47 µg of i
b killed no mice.
In the present work,
approximately 2 ng of purified r i
a
was required to kill 50% of
mice in the presence of approximately 500 ng of i
b. However, 500
µg of purified r i
a
alone showed no lethal activity.
Biological activities of ia with variations at Arg-295,
Glu-14, Glu-226, Glu-378, Glu-380, Ser-338, Ser-340, and Thr-339.
The Arg-295 in ia was replaced with alanine, lysine, and
histidine by site-directed mutagenesis; Glu-14 and -226 were replaced with alanine; Glu-378 and -380 were replaced with alanine, aspartic acid, and glutamine; Ser-338 and -340 were replaced with alanine, cysteine, threonine, and phenylalanine; and Thr-339 was replaced with
alanine and phenylalanine. These variant components were purified from
cultures of B. subtilis transformants carrying the corresponding genes by use of the purification procedure described for
r ia. All of the purified variant components showed only
one band of approximately 43 kDa on SDS-PAGE (data not shown).
R295A showed a complete loss of NADase, ARTase, cytotoxic, and
lethal activities under our experimental conditions (Tables
2,
3, and
4). On the other hand, the NADase,
ARTase, cytotoxic,
and lethal activities of R295K were about 100- to 250-fold lower
than those of the wild-type component (Tables
2,
3,
and
4).
The ARTase and cytotoxic activities of R295H were about
0.2% these
activities in wild-type i
a, but the lethal
activity of R295H was
about 6% the wild-type component activity; these
results show
that replacement of Arg-295 with histidine did not cause a
severe
reduction in lethal activity, compared with the reduction in
enzymatic
and cytotoxic activities. These observations suggest that
Arg-295
is able to be partially substituted by basic amino acids,
judging
from the effect of the replacements on NADase, ARTase,
cytotoxic,
and lethal activities.
Replacement of Glu-14 and -226 had little effect on the ARTase
activity of i
a (Table
2) and did not cause a significant
reduction
in the cytotoxic and lethal activities of i
a in
the presence of
i
b (Tables
3 and
4); these results indicate
that these residues
are not required for the biological activities of
i
a. Replacement
of Glu-378 with alanine resulted in a
complete loss of NADase,
ARTase, cytotoxic, and lethal
activities (Tables
2,
3, and
4),
suggesting that Glu-378 is important
for these activities. Conservative
substitution of aspartic acid for
Glu-378 caused a drastic decrease
in ARTase, lethal, and cytotoxic
activities, below our detection
limit. That of glutamine reduced
ARTase, lethal, and cytotoxic
activities to below our detection
limit. However, replacement
of the residue with aspartic acid and
glutamine had little effect
on NADase activity. These results
suggest that the carboxyl group
of Glu-378 is essential for ARTase,
lethal, and cytotoxic activities
but not for NADase activity. As
shown in Table
2, changing Glu-380
to alanine caused a complete loss of
NADase and ARTase activities,
changing it to aspartic acid
resulted in over a 200-fold reduction
in these enzymatic activities,
and changing it to glutamine reduced
ARTase activity to below our
detection limit. Furthermore, the
cytotoxic and lethal activities of
E380D were about 500 and 1,000
times lower than those of r
i
a, respectively, but these activities
of E380A and E380Q
were below the detection limit (Tables
3 and
4). These observations
show that Glu-380 is essential for any
activities of i
a.
Replacement of Ser-338 with alanine and cysteine resulted in about a
30- to 150-fold reduction in the NADase, ARTase, cytotoxic,
and
lethal activities of wild-type i
a (Tables
2,
3, and
4).
It
is likely that Ser-338 is important but not essential for these
activities. Replacement of Ser-338 with threonine and phenylalanine
caused ARTase, cytotoxic, and lethal activities to fall below
the
detection limit, implying that replacement of Ser-338 with
amino acids
containing large side chains reduced these activities
more severely
than did that with amino acids containing small
side chains.
Replacement of Ser-340 with alanine, cysteine, and
threonine caused
only a 3- to 30-fold reduction in the NADase,
ARTase,
cytotoxic, and lethal activities of wild-type i
a (Tables
2,
3, and
4). Replacement of Thr-339 with alanine or phenylalanine
led to
about a 6- to 30-fold
reduction.
Kinetics of ADP-ribosylating activities of wild-type ia
and variant ia.
Kinetic analyses of the six variant
components (R295K, S338A, T339A, S340A, E378D, and E380D) were
performed to help determine the mechanistic basis for the events caused
by NADase and ARTase in the presence of increasing
NAD+ or actin concentrations. The kinetic parameters were
obtained by analysis of the Hanes-Woolf plots of initial velocities of the NADase reaction. Table 5 shows
that the Km values for NAD+ binding
to E380D, S338A, S340A, and T339A were similar to that of the wild
type. The Km value for binding to R295K was
significantly higher than that of the wild type (2.5-fold higher
Km value), and the kcat values
associated with R295K, S338A, and E380D were considerably lower than
that of the wild type (200-, 67- and 250-fold lower kcat
values, respectively); these results show that the kinetic effects on
these residues almost exclusively involved kcat. The
Km and kcat values for E378D were
similar to those for the wild-type component.
The kinetic parameters obtained by analysis of the Hanes-Woolf plots of
initial velocities for the ARTase reaction are summarized
in Table
6. The
Km values
for NAD
+ binding to the variant components for the
ARTase reaction were
determined from initial rate data obtained at
a fixed actin concentration
and various NAD
+
concentrations. The results showed that the
Km
values of R295K
and S338A were significantly higher than that of the
wild-type
and that the
Km values for the
ARTase activity of T339A, S340A,
E378D, and E380D were identical to
that of the wild type (Table
6); these results show that replacement of
Arg-295 and Ser-338
resulted in a significant alteration of the
Km for NAD
+. Replacement of Arg-295,
Glu-378, and Glu-380 drastically reduced
kcat values. The
kcat values associated with Arg-295, Glu-378,
and Glu-380
were markedly reduced, by 1,000-, 250-, and 1,000-fold,
respectively,
compared to that of the wild type, as shown in Table
6. The
kcat values associated with S338A, T339A, and S340A were
about 5, 20, and 26% that of the wild type, respectively.
Next, the
Km values for actin binding to the
variant i
a components for the ARTase reaction were
determined from initial rate
data obtained at a fixed NAD
+
concentration and various actin concentrations. The
Km values
for actin binding to any variant
components were in agreement
with that determined for the wild type,
within experimental error;
none of the variants showed altered affinity
for actin (Table
6). Replacement of Arg-295, Ser-338, Glu-378, and
Glu-380 resulted
in drastic reductions in
kcat values. The
kcat values associated
with Arg-295, Ser-338, Glu-378, and
Glu-380 were markedly reduced,
by about 125-, 37-, 83-, and 200-fold,
respectively, compared
to that of the wild type as shown in Table
6.
However, replacement
of Thr-339 and Ser-340 reduced by about 78 and
18%, respectively,
the
kcat value associated with the wild
type.
 |
DISCUSSION |
The yield of purified r ia was approximately 35 mg/liter from cultures of the B. subtilis transformant
carrying the ia gene. The N-terminal sequence of r
ia was identical to that of native ia and that
deduced from the ia gene. The molecular mass and
antigenicity of r ia also were coincident with those of
native ia. Based upon the lethal activities of r
ia purified from cultures of the B. subtilis
transformant and of ia purified from C. perfringens cultures by Stiles and Wilkins (43), the
specific activity of the former was calculated to be about 300 times
higher than that of the latter; this result shows that our purification
procedure is very useful for the isolation of large amounts of
ia with high specific activity.
Replacement of Glu-14 and -226, which are included within the
E-X-X-X-X-W sequence involved in the NAD+ binding sites of
DT and ETA (15), had no effect on the activities of
ia, confirming that ia belongs to the CT group
of in the ADP-ribosylating enzyme family (14).
Replacement of Arg-295 with alanine in ia led to a complete
loss of NADase, ARTase, lethal, and cytotoxic activities.
Perelle et al. (31) also reported that this
residue is essential for ARTase activity. Thus, it appears that
Arg-295 of ia is equivalent to Arg-7 of LT and Arg-299 of
C2 toxin, which are required for ARTase activity (6,
15). However, replacement of Arg-295 with histidine or lysine
caused a drastic reduction in NADase and/or ARTase activities,
although the activities were still detectable, showing that the charge
of the basic side chain of Arg-295 is essential for the NADase and
ARTase activities of ia. Substitution of lysine for
Arg-295 in ia resulted in a significant reduction in
the Km for NAD+, markedly reduced
the kcat values for NADase and ARTase, but had
little effect on the Km for actin. Accordingly,
these observations suggest that Arg-295 plays an essential
role in both the binding of ia to NAD+
and the catalytic actions of NADase and ARTase (Fig.
3).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Active-site structure of LT. This active-site
configuration was drawn on the basis of the refined coordinates of LT
(41). The Arg-7 (R7), Ser-61 (S61), Thr-62 (T62), Ser-63
(S63), Glu-110 (E110), and Glu-112 (E112) side chains are shown in
bold. (B) Sequence alignments of LT and the ia component.
Sequences were taken from porcine LT (SWISSProt accession no., P06717)
and component ia (GenBank accession no., X73562). The
residues in bold are those that are conserved in ADP-ribosylating
enzymes.
|
|
Substitution of Glu-378 with alanine in ia resulted in a
complete loss of NADase and ARTase activities, as reported by
Perelle et al. (31); however, conservative substitution of
Glu-378 with aspartic acid or glutamine in ia had little
effect on NADase activity and drastically reduced but did not
diminish ARTase activity. These results indicate that Glu-378 plays
an important role in ARTase activity but not in NADase
activity. It therefore is likely that the side chain of the amino acid
at position 378 is important for maintenance of the active-site
integrity in NADase activity and that the carboxyl group of the
amino acid at position 378 is essential for ARTase activity.
Glu-378 within the E-X-E motif (Glu378-X-Glu379) of C2 toxin and Glu-379
within the motif Glu379-X-Glu381 of ExoS were
essential for ARTase activity but were not required for
NADase activity (6, 33). Our results coincided
with these results.
The kinetic analysis showed that replacement of Glu-378 with aspartic
acid resulted in a severe reduction in the kcat values for
ARTase activity but had little effect on the
Km values for NAD+ and actin,
suggesting that the residue plays an important role in catalytic
mechanism but is not required for binding to NAD+ and
actin. The glutamic acid at position 380 could be replaced with
aspartic acid, although the replacement was not wholly effective, but
could not be replaced with alanine and glutamine; these results show
that conservative substitution, such as reduction of the carboxyl group
at position 380 by one methylene unit or replacement of the carboxyl
group by an uncharged amide, resulted in a significant reduction and a
complete loss, respectively, of ARTase activity. Thus, the role of
Glu-380 in ia appears to be equivalent to that of the
corresponding residues in C2 toxin and LT.
Replacement of Glu-380 with aspartic acid markedly reduced the
kcat values for ARTase and had little effect on the
Km values for NAD+ and actin,
suggesting that Glu-380 is essential for the catalytic mechanism of
ARTase but not for binding to NAD+ and actin. Damme et
al. (13) reported the Glu-378 in ia was photolabeled by NAD+ but that Glu-380 was not. Therefore,
the Glu-378 and -380 residues seem to play different roles in the
ARTase activity of ia.
Cieplak et al. (10) reported that substitution of Glu-112
(E110-X-E112) in LT resulted in a marked
reduction in ARTase activity, suggesting that the residue plays a
specific role in the mechanism of ADP-ribosylation and represents an
essential catalytic residue. In addition, they suggested that Glu-110
is unlikely to play a specific role in the reaction mechanism. Hara et
al. (19) reported that rat T-cell antigen RT 6.1 (Q207-X-E209) catalyzes NAD+
glycohydrolysis but not NAD+ ribosyltransfer and that
mutant RT 6.1 in which Gln-207 was replaced with glutamic acid
exhibited ARTase activity. Our result is coincident with their
findings in that the first glutamic acid residue in the E-X-E motif is
essential for ARTase activity but not for NADase activity.
However, C3 and EDIN in the ADP-ribosyltransferase family, which
ADP-ribosylate small GTP-binding proteins of the rho family, have a
glutamine residue in the motif, suggesting that the residue in C3 and
EDIN which corresponds to the residue at position 380 in ia
is not required to be glutamic acid for ARTase activity. Thus, the
residue in the motif may depend on the substrate.
Ser-338 could be replaced with alanine and cysteine, although the
replacements were not wholly effective, but could not be replaced with
threonine and phenylalanine; these results suggest that the hydroxyl
group of Ser-338 is not essential for these activities and that the
large side chain of the amino acid at position 338 completely disturbed
ARTase activity. Thus, Ser-338 may be extremely close to the
catalytic site, as shown in Fig. 3. Replacement of Ser-338 with alanine
caused a significant reduction in the Km value
of NAD+ for ARTase and drastically reduced the
kcat values for NADase and ARTase activities. These
observations imply that the side chain of the amino acid position at
338 is required for maintenance of the NAD+-binding site
and catalytic site in these activities.
Bell and Eisenberg (7) reported that the S-T-S motif in DT
binds to either the ribose or the phosphate of the AMP moiety of
NAD+. Furthermore, Barth et al. (6) reported
that Ser-348 in the motif S348-T-S350 in C2
toxin may play an essential role in NAD+ binding or
catalysis. There is no contradiction between our results and their
model. Replacement of Thr-339 or Ser-340 with alanine resulted in a
significant but not severe reduction in NADase and ARTase
activities. Replacement of Thr-339 and Ser-340 did not result in a
drastic reduction in the Km and kcat
values for NADase or ARTase, compared with that of Ser-338,
suggesting that these residues do not play an important role in binding
and catalytic reactions, as shown in Fig. 3.
NADase and ARTase activities catalyze the cleavage of the
N-glycosidic bond of NAD+; the former transfers the
ADP-ribose moiety to water, and the latter transfers the moiety to
actin. Thus, it seems that Arg-298, Ser-338 and Glu-380, required for
these activities in ia, play an important role in the
cleavage of the N-glycosidic bond of NAD+ and that Glu-378,
required for ARTase activity but not for NADase activity, is
essential for the transfer of the ADP-ribose moiety to actin.
From these observations, changes in ARTase activity as a result of
the substitution of various amino acid residues in ia were on the whole similar to those in cytotoxic and lethal activities, except for changes in these activities in R295H. It therefore is likely
that the cytotoxicity and lethality of iota-toxin are closely related
to the ARTase activity of ia.
 |
ACKNOWLEDGMENTS |
We thank Keiko Yamamoto and Akiko Maeda for competent technical assistance.
This research was supported in part by a grant from the Ministry of
Education, Science, and Culture of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri
University, Yamashiro-cho, Tokushima 770-8514, Japan. Phone: 81 088-622-9611. Fax: 81 088-655-3051. E-mail:
sakurai{at}ph.bunri-u.ac.jp.
 |
REFERENCES |
| 1.
|
Aktories, K.
1990.
Clostridial ADP-ribosyltransferases modification of low molecular weight GTP-binding proteins and of actin by clostridial toxins.
Med. Microbiol. Immunol.
179:123-136[Medline].
|
| 2.
|
Aktories, K.
1994.
Clostridial ADP-ribosylating toxins: effects on ATP and GTP-binding proteins.
Mol. Cell. Biochem.
138:167-176[CrossRef][Medline].
|
| 3.
|
Aktories, K., and A. Wegner.
1989.
ADP-ribosylation of actin by clostridial toxins.
J. Cell Biol.
109:1385-1387[Free Full Text].
|
| 4.
|
Aktories, K.,
M. Barmann,
I. Ohishi,
S. Tsuyama,
K. H. Jakobs, and E. Habermann.
1986.
Botulinum C2 toxin ADP-ribosylates actin.
Nature
322:390-392[CrossRef][Medline].
|
| 5.
|
Aktories, K.,
S. Rosener,
U. Blaschke, and G. S. Chhatwal.
1988.
Botulinum ADP-ribosyltransferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes.
Eur. J. Biochem.
172:445-450[Medline].
|
| 6.
|
Barth, H.,
J. C. Preiss,
F. Hofmann, and K. Aktories.
1998.
Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis.
J. Biol. Chem.
273:29506-29511[Abstract/Free Full Text].
|
| 7.
|
Bell, C. E., and D. Eisenberg.
1996.
Crystal structure of nucleotide-free diphtheria toxin.
Biochemistry
35:1137-1149[CrossRef][Medline].
|
| 8.
|
Borriello, S. P., and R. J. Carman.
1983.
Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits.
J. Clin. Microbiol.
17:414-418[Abstract/Free Full Text].
|
| 9.
|
Carman, R. J., and S. P. Borriello.
1982.
Observation on an association between Clostridium spiroforme and Clostridium perfringens type E iota enterotoxaemia in rabbits.
Eur. J. Chemother. Antibiol.
2:143-144.
|
| 10.
|
Cieplak, W.,
D. J. Mead,
R. J. Messer, and C. C. R. Grant.
1995.
Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli heat-labile enterotoxin. Evidence for a catalytic role for glutamic acid 112.
J. Biol. Chem.
270:30545-30550[Abstract/Free Full Text].
|
| 11.
|
Collier, R. J.
1975.
Diphtheria toxin: mode of action and structure.
Bacteriol. Rev.
39:54-85[Free Full Text].
|
| 12.
|
Considine, R. V., and L. L. Simpson.
1991.
Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity.
Toxicon
29:913-936[Medline].
|
| 13.
|
Damme, J.,
M. Jung,
F. Hofmann,
I. Just,
J. Vandekerckhove, and K. Aktories.
1996.
Analysis of the catalytic site of the actin ADP-ribosylating Clostridium perfringens iota toxin.
FEBS Lett.
380:291-295[CrossRef][Medline].
|
| 14.
|
Domenighini, M., and R. Rappuoli.
1996.
Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages.
Mol. Microbiol.
21:667-674[CrossRef][Medline].
|
| 15.
|
Domenighini, M.,
C. Montecucco,
W. C. Ripka, and R. Rappuoli.
1991.
Computer modeling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
Mol. Microbiol.
5:23-31[CrossRef][Medline].
|
| 16.
|
Eaton, P., and D. S. Fernie.
1980.
Enterotoxaemia involving Clostridium perfringens iota toxin in a hysterectomy-derived rabbit colony.
Lab. Anim.
14:347-351[Abstract/Free Full Text].
|
| 17.
|
Fernie, D. S.,
J. M. Knights,
R. O. Thomson, and R. J. Carman.
1984.
Rabbit enterotoxaemia: purification and preliminary characterization of a toxin produced by Clostridium spiroforme.
FEMS Microbiol. Lett.
21:207-211[CrossRef].
|
| 18.
|
Hanes, C. S.
1932.
CLXVII. Studies on plant amylases. I. The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley.
Biochem. J.
26:1406-1421.
|
| 19.
|
Hara, N.,
M. Tsuchiya, and M. Shimoyama.
1996.
Glutamic acid 207 in rodent T-cell RT6 antigens is essential for arginine-specific ADP-ribosylation.
J. Biol. Chem.
271:29552-29555[Abstract/Free Full Text].
|
| 20.
|
Holmes, H. T.,
R. J. Sonn, and N. M. Patton.
1988.
Isolation of Clostridium spiroforme from rabbits.
Lab. Anim. Sci.
38:167-168[Medline].
|
| 21.
|
Hunter, S. E. C.,
J. E. Brown,
P. C. F. Oyston,
J. Sakurai, and R. W. Titball.
1993.
Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus.
Infect. Immun.
61:3958-3965[Abstract/Free Full Text].
|
| 22.
|
Kaslow, H. R.,
L. K. Lim,
J. Moss, and D. D. Lesikar.
1987.
Structure-activity analysis of the activation of pertussis toxin.
Biochemistry
26:123-127[CrossRef][Medline].
|
| 23.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 24.
|
Liu, S.,
S. M. Kulich, and J. T. Barbieri.
1996.
Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S.
Biochemistry
35:2754-2758[CrossRef][Medline].
|
| 25.
|
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 26.
|
McDonel, J. L.
1986.
Toxins of Clostridium perfringens types A, B, C, D, and E, p. 477-517.
In
F. Dorner, and J. Drews (ed.), Pharmacology of bacterial toxins. Pergamon Press, Oxford, England.
|
| 27.
|
Nagahama, M.,
H. Iida,
E. Nishioka,
K. Okamoto, and J. Sakurai.
1994.
Roles of the carboxy-terminal region of Clostridium perfringens alpha toxin.
FEMS Microbiol. Lett.
120:297-302[CrossRef][Medline].
|
| 28.
|
Nagahama, M.,
Y. Okagawa,
T. Nakayama,
E. Nishioka, and J. Sakurai.
1995.
Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.
J. Bacteriol.
177:1179-1185[Abstract/Free Full Text].
|
| 29.
|
Nagahama, M.,
T. Nakayama,
K. Michiue, and J. Sakurai.
1997.
Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.
Infect. Immun.
65:3489-3492[Abstract].
|
| 30.
|
Perelle, S.,
M. Gibert,
P. Boquet, and M. R. Popoff.
1993.
Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli.
Infect. Immun.
61:5147-5156[Abstract/Free Full Text]. (Author's correction, 63:4967, 1995.)
|
| 31.
|
Perelle, S.,
M. Domenighini, and M. R. Popoff.
1996.
Evidence that Arg-295, Glu-378, and Glu-380 are active-site residues of the ADP-ribosyltransferase activity of iota toxin.
FEBS Lett.
395:191-194[CrossRef][Medline].
|
| 32.
|
Popoff, M. R., and P. Boquet.
1988.
Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin.
Biochem. Biophys. Res. Commun.
152:1361-1368[CrossRef][Medline].
|
| 33.
|
Radke, J.,
K. J. Pederson, and J. T. Barbieri.
1999.
Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.
Infect. Immun.
67:1508-1510[Abstract/Free Full Text].
|
| 34.
|
Reuner, K. H.,
P. Presek,
C. B. Boschek, and K. Aktories.
1987.
Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells.
Eur. J. Cell Biol.
43:134-140[Medline].
|
| 35.
|
Sakurai, J.
1995.
Toxins of Clostridium perfringens.
Rev. Med. Microbiol.
6:175-185.
|
| 36.
|
Sakurai, J., and K. Kobayashi.
1995.
Lethal and dermonecrotic activities of Clostridium perfringens iota toxin: biological activities induced by cooperation of two nonlinked components.
Microbiol. Immunol.
39:249-253[Medline].
|
| 37.
|
Sakurai, J.,
M. Nagahama, and S. Ochi.
1997.
Major toxins of Clostridium perfringens.
J. Toxicol.-Toxin Rev.
16:195-214.
|
| 38.
|
Schering, B.,
M. Barmann,
G. S. Chhatwal,
U. Geipel, and K. Aktories.
1988.
ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin.
Eur. J. Biochem.
171:225-229[Medline].
|
| 39.
|
Simonen, M., and I. Paya.
1993.
Protein secretion in Bacillus species.
Microbiol. Rev.
57:109-137[Abstract/Free Full Text].
|
| 40.
|
Simpson, L. L.,
B. G. Stiles,
H. H. Zepeda, and T. D. Wilkins.
1987.
Molecular basis for the pathological actions of Clostridium perfringens iota toxin.
Infect. Immun.
55:118-122[Abstract/Free Full Text].
|
| 41.
|
Sixma, T. K.,
K. H. Kalk,
B. A. van Santen,
Z. Dauter,
J. Kingma,
B. Witholt, and W. G. Hol.
1993.
Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin.
J. Mol. Biol.
230:890-918[CrossRef][Medline].
|
| 42.
|
Spangler, B. D.
1992.
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.
Microbiol. Rev.
56:622-647[Abstract/Free Full Text].
|
| 43.
|
Stiles, B. G., and T. D. Wilkins.
1986.
Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity.
Infect. Immun.
54:683-688[Abstract/Free Full Text].
|
| 44.
|
Sugai, M.,
T. Enomoto,
K. Hashimoto,
K. Matsumoto,
Y. Matsuo,
H. Ohgai,
Y. M. Hong,
S. Inoue,
K. Yoshikawa, and H. Suginaka.
1990.
A novel epidermal cell differentiation inhibitor (EDIN): purification and characterization from Staphylococcus aureus.
Biochem. Biophys. Res. Commun.
173:92-98[CrossRef][Medline].
|
| 45.
|
Wick, M. J.,
D. W. Frank,
D. G. Storey, and B. H. Iglewski.
1990.
Structure, function, and regulation of Pseudomonas aeruginosa exotoxin A.
Annu. Rev. Microbiol.
44:335-363[CrossRef][Medline].
|
| 46.
|
Xu, Y.,
V. Barbarcon-Finck, and J. T. Barbieri.
1994.
Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.
J. Biol. Chem.
269:9993-9999[Abstract/Free Full Text].
|
Journal of Bacteriology, April 2000, p. 2096-2103, Vol. 182, No. 8
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sundriyal, A., Roberts, A. K., Shone, C. C., Acharya, K. R.
(2009). Structural Basis for Substrate Recognition in the Enzymatic Component of ADP-ribosyltransferase Toxin CDTa from Clostridium difficile. J. Biol. Chem.
284: 28713-28719
[Abstract]
[Full Text]
-
Tsuge, H., Nagahama, M., Oda, M., Iwamoto, S., Utsunomiya, H., Marquez, V. E., Katunuma, N., Nishizawa, M., Sakurai, J.
(2008). Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens {iota}-toxin. Proc. Natl. Acad. Sci. USA
105: 7399-7404
[Abstract]
[Full Text]
-
Fehr, D., Burr, S. E., Gibert, M., d'Alayer, J., Frey, J., Popoff, M. R.
(2007). Aeromonas Exoenzyme T of Aeromonas salmonicida Is a Bifunctional Protein That Targets the Host Cytoskeleton. J. Biol. Chem.
282: 28843-28852
[Abstract]
[Full Text]
-
O'Neal, C. J., Jobling, M. G., Holmes, R. K., Hol, W. G. J.
(2005). Structural Basis for the Activation of Cholera Toxin by Human ARF6-GTP. Science
309: 1093-1096
[Abstract]
[Full Text]
-
Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G.
(2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev.
68: 373-402
[Abstract]
[Full Text]
-
Nagahama, M., Yamaguchi, A., Hagiyama, T., Ohkubo, N., Kobayashi, K., Sakurai, J.
(2004). Binding and Internalization of Clostridium perfringens Iota-Toxin in Lipid Rafts. Infect. Immun.
72: 3267-3275
[Abstract]
[Full Text]
-
Evans, H. R., Sutton, J. M., Holloway, D. E., Ayriss, J., Shone, C. C., Acharya, K. R.
(2003). The Crystal Structure of C3stau2 from Staphylococcus aureus and Its Complex with NAD. J. Biol. Chem.
278: 45924-45930
[Abstract]
[Full Text]
-
Nagahama, M., Nagayasu, K., Kobayashi, K., Sakurai, J.
(2002). Binding Component of Clostridium perfringens Iota-Toxin Induces Endocytosis in Vero Cells. Infect. Immun.
70: 1909-1914
[Abstract]
[Full Text]
-
Knapp, O., Benz, R., Gibert, M., Marvaud, J. C., Popoff, M. R.
(2002). Interaction of Clostridium perfringens Iota-Toxin with Lipid Bilayer Membranes. DEMONSTRATION OF CHANNEL FORMATION BY THE ACTIVATED BINDING COMPONENT Ib AND CHANNEL BLOCK BY THE ENZYME COMPONENT Ia. J. Biol. Chem.
277: 6143-6152
[Abstract]
[Full Text]
-
Marvaud, J.-C., Smith, T., Hale, M. L., Popoff, M. R., Smith, L. A., Stiles, B. G.
(2001). Clostridium perfringens Iota-Toxin: Mapping of Receptor Binding and Ia Docking Domains on Ib. Infect. Immun.
69: 2435-2441
[Abstract]
[Full Text]
-
Stabb, E. V., Reich, K. A., Ruby, E. G.
(2001). Vibrio fischeri Genes hvnA and hvnB Encode Secreted NAD+-Glycohydrolases. J. Bacteriol.
183: 309-317
[Abstract]
[Full Text]